Skip to main content
Erschienen in: International Journal of Hematology 2/2018

04.04.2018 | Original Article

Effects of plasma glycosyltransferase on the ABO(H) blood group antigens of human von Willebrand factor

verfasst von: Taiki Kano, Kazunao Kondo, Jiharu Hamako, Fumio Matsushita, Kazuya Sakai, Taei Matsui

Erschienen in: International Journal of Hematology | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Von Willebrand factor (VWF) is one of the plasma protein carrying ABO(H) blood group antigens, but the combining process of these antigens is not clear. In the present study, we examined whether plasma glycosyltransferase affects the blood group antigens on VWF. VWF expressing H-antigen (H-VWF) from blood group O and bovine serum albumin conjugated with H-antigen (H-BSA) were incubated with recombinant α1-3-N-acetylgalactosaminyltransferase (rA-transferase) and A-plasma with or without an additional UDP-GalNAc. Transformed antigens were detected by western blotting and ELISA, using an anti-A antibody. Both H-VWF and H-BSA acquired the A-antigen after incubation with rA-transferase and UDP-GalNAc. Incubation with A-plasma very weakly converted the H-antigen on BSA and VWF to A-antigen only in the presence of supplemented UDP-GalNAc. This conversion was enhanced on desialylation of H-VWF. These results indicate that sugar chains of plasma VWF can be modified by the external glycosyltransferase, but that plasma glycosyltransferase has no effect on the blood group antigens of VWF due to its low activity and the lack of donor sugars. Further, sialic acid residues of VWF may exert a protective effect against post-translational glycosylation. Our results clearly exclude the possibility that blood group antigens of VWF are constructed extracellularly in plasma.
Literatur
1.
Zurück zum Zitat Franchini M, Mannucci PM. von Willebrand factor: another janus-faced hemostasis protein. Semin Thromb Hemost. 2008;34:663–9.CrossRefPubMed Franchini M, Mannucci PM. von Willebrand factor: another janus-faced hemostasis protein. Semin Thromb Hemost. 2008;34:663–9.CrossRefPubMed
2.
3.
Zurück zum Zitat Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395–424.CrossRefPubMed Sadler JE. Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem. 1998;67:395–424.CrossRefPubMed
4.
Zurück zum Zitat Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84:160–74.CrossRefPubMed Sadler JE, Mannucci PM, Berntorp E, Bochkov N, Boulyjenkov V, Ginsburg D, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84:160–74.CrossRefPubMed
5.
Zurück zum Zitat Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, et al. Amino acid sequence of human von Willebrand factor. Biochemistry. 1986;25:3171–84.CrossRefPubMed Titani K, Kumar S, Takio K, Ericsson LH, Wade RD, Ashida K, et al. Amino acid sequence of human von Willebrand factor. Biochemistry. 1986;25:3171–84.CrossRefPubMed
6.
Zurück zum Zitat Canis K, McKinnon TA, Nowak A, Haslam SM, Panico M, Morris HR, et al. Mapping the N-glycome of human von Willebrand factor. Biochem J. 2012;447:217–28.CrossRefPubMed Canis K, McKinnon TA, Nowak A, Haslam SM, Panico M, Morris HR, et al. Mapping the N-glycome of human von Willebrand factor. Biochem J. 2012;447:217–28.CrossRefPubMed
7.
8.
Zurück zum Zitat Samor B, Michalski J, Mazurier C, Goudemand M, Waard P, Vliegenthart JFG, et al. Primary structure of the major O-glycosidically linked carbohydrate unit of human von Willebrand factor. Glycoconj J. 1989;6:263–70.CrossRefPubMed Samor B, Michalski J, Mazurier C, Goudemand M, Waard P, Vliegenthart JFG, et al. Primary structure of the major O-glycosidically linked carbohydrate unit of human von Willebrand factor. Glycoconj J. 1989;6:263–70.CrossRefPubMed
9.
Zurück zum Zitat Matsui T, Titani K, Mizuochi T. Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem. 1992;267:8723–31.PubMed Matsui T, Titani K, Mizuochi T. Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem. 1992;267:8723–31.PubMed
10.
Zurück zum Zitat Schulte am Esch J 2nd, Robson SC, Knoefel WT, Eisenberger CF, Peiper M, Rogiers X. Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction. Br J Haematol. 2005;128:82–90.CrossRefPubMed Schulte am Esch J 2nd, Robson SC, Knoefel WT, Eisenberger CF, Peiper M, Rogiers X. Impact of O-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction. Br J Haematol. 2005;128:82–90.CrossRefPubMed
11.
Zurück zum Zitat Nowak AA, Canis K, Riddell A, Laffan MA, McKinnon TA. O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions. Blood. 2012;120:214–22.CrossRefPubMed Nowak AA, Canis K, Riddell A, Laffan MA, McKinnon TA. O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions. Blood. 2012;120:214–22.CrossRefPubMed
12.
Zurück zum Zitat Denis CV, Christophe OD, Oortwijn BD, Lenting PJ. Clearance of von Willebrand factor. Thromb Haemost. 2008;99:271–8.PubMed Denis CV, Christophe OD, Oortwijn BD, Lenting PJ. Clearance of von Willebrand factor. Thromb Haemost. 2008;99:271–8.PubMed
13.
Zurück zum Zitat Matsui T, Fujimura Y, Nishida S, Titani K. Human plasma alpha 2-macroglobulin and von Willebrand factor possess covalently linked ABO(H) blood group antigens in subjects with corresponding ABO phenotype. Blood. 1993;82:663–8.PubMed Matsui T, Fujimura Y, Nishida S, Titani K. Human plasma alpha 2-macroglobulin and von Willebrand factor possess covalently linked ABO(H) blood group antigens in subjects with corresponding ABO phenotype. Blood. 1993;82:663–8.PubMed
14.
Zurück zum Zitat Matsui T, Titani K. ABO(H) blood group expression on circulating glycoproteins. Methods Mol Med. 1998;9:235–45.PubMed Matsui T, Titani K. ABO(H) blood group expression on circulating glycoproteins. Methods Mol Med. 1998;9:235–45.PubMed
15.
Zurück zum Zitat Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987;69:1691–5.PubMed Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ Jr, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood. 1987;69:1691–5.PubMed
16.
Zurück zum Zitat Shima M, Fujimura Y, Nishiyama T, Tsujiuchi T, Narita N, Matsui T, et al. ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang. 1995;68:236–40.CrossRefPubMed Shima M, Fujimura Y, Nishiyama T, Tsujiuchi T, Narita N, Matsui T, et al. ABO blood group genotype and plasma von Willebrand factor in normal individuals. Vox Sang. 1995;68:236–40.CrossRefPubMed
17.
Zurück zum Zitat O’Donnell J, Boulton FE, Manning RA, Laffan MA. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arterioscler Thromb Vasc Biol. 2002;22:335–41.CrossRefPubMed O’Donnell J, Boulton FE, Manning RA, Laffan MA. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arterioscler Thromb Vasc Biol. 2002;22:335–41.CrossRefPubMed
18.
Zurück zum Zitat O’Donnell J, McKinnon TA, Crawley JT, Lane DA, Laffan MA. Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis. Blood. 2005;106:1988–91.CrossRefPubMed O’Donnell J, McKinnon TA, Crawley JT, Lane DA, Laffan MA. Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis. Blood. 2005;106:1988–91.CrossRefPubMed
19.
Zurück zum Zitat Liumbruno GM, Franchini M. Beyond immunohematology: the role of the ABO blood group in human diseases. Blood Transfus. 2013;11:491–9.PubMedPubMedCentral Liumbruno GM, Franchini M. Beyond immunohematology: the role of the ABO blood group in human diseases. Blood Transfus. 2013;11:491–9.PubMedPubMedCentral
20.
Zurück zum Zitat Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci. 2012;49:137–49.CrossRefPubMed Franchini M, Favaloro EJ, Targher G, Lippi G. ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci. 2012;49:137–49.CrossRefPubMed
21.
22.
Zurück zum Zitat Watkins WM. Biochemistry and genetics of the ABO, Lewis, and P blood group systems. Adv Hum Genet. 1980;10:1–136.PubMed Watkins WM. Biochemistry and genetics of the ABO, Lewis, and P blood group systems. Adv Hum Genet. 1980;10:1–136.PubMed
23.
Zurück zum Zitat Morgan WT. The Croonian lecture: a contribution to human biochemical genetics; the chemical basis of blood-group specificity. Proc R Soc Lond B Biol Sci. 1960;151:308–47.CrossRefPubMed Morgan WT. The Croonian lecture: a contribution to human biochemical genetics; the chemical basis of blood-group specificity. Proc R Soc Lond B Biol Sci. 1960;151:308–47.CrossRefPubMed
24.
Zurück zum Zitat Matsui T, Shimoyama T, Matsumoto M, Fujimura Y, Takemoto Y, Sako M, et al. ABO blood group antigens on human plasma von Willebrand factor after ABO-mismatched bone marrow transplantation. Blood. 1999;94:2895–900.PubMed Matsui T, Shimoyama T, Matsumoto M, Fujimura Y, Takemoto Y, Sako M, et al. ABO blood group antigens on human plasma von Willebrand factor after ABO-mismatched bone marrow transplantation. Blood. 1999;94:2895–900.PubMed
25.
Zurück zum Zitat Brown SA, Collins PW, Bowen DJ. Heterogeneous detection of A-antigen on von Willebrand factor derived from platelets, endothelial cells and plasma. Thromb Haemost. 2002;87:990–6.CrossRefPubMed Brown SA, Collins PW, Bowen DJ. Heterogeneous detection of A-antigen on von Willebrand factor derived from platelets, endothelial cells and plasma. Thromb Haemost. 2002;87:990–6.CrossRefPubMed
26.
Zurück zum Zitat O’Donnell J, Laffan MA. Dissociation of ABH antigen expression from von Willebrand factor synthesis in endothelial cell lines. Br J Haematol. 2003;121:928–31.CrossRefPubMed O’Donnell J, Laffan MA. Dissociation of ABH antigen expression from von Willebrand factor synthesis in endothelial cell lines. Br J Haematol. 2003;121:928–31.CrossRefPubMed
27.
Zurück zum Zitat Whitehead JS, Bella A Jr, Kim YS. An N-acetylgalactosaminyltransferase from human blood group A plasma I. Purification and agarose binding properties. J Biol Chem. 1974;249:3442–7. Whitehead JS, Bella A Jr, Kim YS. An N-acetylgalactosaminyltransferase from human blood group A plasma I. Purification and agarose binding properties. J Biol Chem. 1974;249:3442–7.
28.
Zurück zum Zitat Katayama M, Hirai S, Kato I, Titani K. Immunoenzymometric analysis for plasma von Willebrand factor degradation in diabetes mellitus using monoclonal antibodies recognizing protease-sensitive sites. Clin Biochem. 1994;27(2):123–31.CrossRefPubMed Katayama M, Hirai S, Kato I, Titani K. Immunoenzymometric analysis for plasma von Willebrand factor degradation in diabetes mellitus using monoclonal antibodies recognizing protease-sensitive sites. Clin Biochem. 1994;27(2):123–31.CrossRefPubMed
29.
Zurück zum Zitat Matsumoto M, Kawaguchi S, Ishizashi H, Yagi H, Iida J, Sakaki T, et al. Platelets treated with ticlopidine are less reactive to unusually large von Willebrand factor multimers than are those treated with aspirin under high shear stress. Pathophysiol Haemost Thromb. 2005;34(1):35–40.CrossRefPubMed Matsumoto M, Kawaguchi S, Ishizashi H, Yagi H, Iida J, Sakaki T, et al. Platelets treated with ticlopidine are less reactive to unusually large von Willebrand factor multimers than are those treated with aspirin under high shear stress. Pathophysiol Haemost Thromb. 2005;34(1):35–40.CrossRefPubMed
30.
Zurück zum Zitat Yoshida A, Schmidt GM, Blume KG, Beutler E. Plasma blood group glycosyltransferase activities after bone marrow transplantation. Blood. 1980;55:699–701.PubMed Yoshida A, Schmidt GM, Blume KG, Beutler E. Plasma blood group glycosyltransferase activities after bone marrow transplantation. Blood. 1980;55:699–701.PubMed
31.
Metadaten
Titel
Effects of plasma glycosyltransferase on the ABO(H) blood group antigens of human von Willebrand factor
verfasst von
Taiki Kano
Kazunao Kondo
Jiharu Hamako
Fumio Matsushita
Kazuya Sakai
Taei Matsui
Publikationsdatum
04.04.2018
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 2/2018
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-018-2452-0

Weitere Artikel der Ausgabe 2/2018

International Journal of Hematology 2/2018 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.